About Us.

We are passionate about our work. We enjoy surmounting challenges.
We are proud of our collaborative culture, transparency, and flat hierarchy.

Mission

Our mission is to improve patient lives by enabling precision medicine through non-invasive diagnostic tests providing actionable health information that is accessible to everyone at any time.

We facilitate the early detection, prevention and management of disease. We empower people to live better lives.

Core Values

Innovation

We always strive to continuously improve every part of the company, from products, to research and development, production, sales and marketing, and human resources.

Patient Focused

Patients are our primary focus. We strive to develop solutions that improve the lives of patients. We are committed to making our solutions available as rapidly and affordably as possible to everyone in any setting.

Integrity

We know who we are and what we stand for. We are accountable for our actions and decisions. We act honestly and ethically. We always strive to be objective and follow the scientific method. We are data driven and transparent with our customers, partners and employees.

Valour

Patients are our primary focus. We strive to develop solutions that improve the lives of patients. We are committed to making our solutions available as rapidly and affordably as possible to everyone in any setting.

Collaboration

Big things can only be accomplished with a great team. We foster active collaboration amongst employees. We believe work in life sciences is never done in a vacuum and can only be accomplished through meaningful collaboration with great partners.

Excellence

In our every undertaking, we commit to excellence reflected in the quality of our products, services, data we generate and customer experience. We aim to be better than our former selves.

Management Team.

Dr. Luc Gervais

Dr. Luc Gervais

Founder, CEO

Luc is an experienced entrepreneur, biotechnology researcher and engineer. Luc is the founder and CEO of 1Drop Diagnostics. He has gained research experience at IBM Research – Zurich and Boehringer Ingelheim Research. He has gained entrepreneurial experience working for startups Biophage Pharma, Unlikely Games and Steltor (acquired by Oracle).

Luc holds a Ph.D. in Microsystems and Microelectronics from the Swiss Federal Institute of Technology Lausanne (EPFL), an M.Sc. in Electrical and Computer Engineering from the University of Alberta and the Canadian National Institute for Nanotechnology, a Chinese Language Certificate from National Taiwan University, and a B.Eng. in Electrical and Computer Engineering from Concordia University.

linked-in email

Dr. Jörg Ziegler

Dr. Jörg Ziegler

Co-Founder, CTO

Jörg is an experienced biophysicist, biochemist and computer scientist. Jörg is the co-founder of 1Drop Diagnostics. He has gained research experience at IBM Research – Zürich and at the Japan Tsukuba National Institute of Material Science. He gained entrepreneurial experience working for software start-ups in Switzerland.

Jörg was a postdoctoral fellow in Biochemistry from the University of Zürich, holds a Ph.D. in Biophysics from the University of Basel, and an M.Sc. in Computer Science from the University of Fribourg and the Tokyo Institute of Technology.

linked-in email

Scientific Advisors.

Prof. Nico de Rooij

Prof. Nico de Rooij

Prof. Nico de Rooij is professor and head of the Sensors, Actuators and Microsystems Laboratory of EPFL (EPFL STI IMT SAMLAB). He is also vice-president of CSEM SA, where he is responsible for the EPF CSEM coordination. His research activities include the design, microfabrication and application of miniaturized silicon based sensors, actuators, and microsystems. He has authored and coauthored over 300 published journal papers in these areas. Nico de Rooij is a Fellow of both the IEEE and the Institute of Physics (UK).

He received the IEEE Jun-Ichi Nishizawa Gold Medal and Schlumberger Prize. He was also awarded a Visiting Investigatorship Program (VIP) in MEMS/NEMS Systems by A*STAR’s Science and Engineering Council (SERC), Singapore, hosted by SIMTech.

linked-in email

Dr. Markus Ehrat

Dr. Markus Ehrat

Dr. Markus Ehrat has a long standing and successful career in life sciences, substantiated in start-up companies as well as in multinational enterprises. Markus was the Head of Department Bioanalytical Research at Ciba-Geigy/Novartis Pharma Basel. He was a founder, the CEO and a member of the board of directors of Zeptosens and, as head of the Division Zeptosens, a member of the management board of Bayer (Schweiz) AG. Since 2012 Markus has a mandate of the Commission of Technology and Innovation (CTI) as head innovation mentor.

Markus holds a Ph.D. and M.Sc. in natural sciences from the Swiss Federal Institute of Technology Zürich (ETHZ). Markus is author or coauthor of more than 70 scientific publications and contributed as inventor to 18 patent families.

linked-in email

Prof. Hans Peter Herzig

Prof. Hans Peter Herzig

Prof. Hans Peter Herzig is professor and head of the Optics & Photonics Technology Laboratory of EPFL (EPFL IMT OPT) and Past President of the European Optical Society (EOS). His current research interests include refractive and diffractive micro-optics, nano-scale optics, and optical microsystems. He started his career 1978 in industry with the company Kern, Aarau, Switzerland, before entering the University of Neuchâtel in 1983. In 2009, he joined the faculty with the EPFL.

Dr. Herzig served as the Conference Chairman for international conferences of EOS, IEE, IEEE/LEOS, OSA, and SPIE. He is the Editor of a well-known book on micro-optics (published in English and Chinese), author of 14 book chapters and over 150 journal papers.

linked-in 

Prof. Per Magnus Kristiansen

Prof. Per Magnus Kristiansen

Prof. Dr. Per Magnus Kristiansen is deputy head of the Institutes of Polymer Nanotechnology (INKA) and Polymer Engineering (IKT) at the University of Applied Sciences and Arts Northwestern Switzerland (FHNW), co-founder of the Swiss Plastics network and expert committee member of the Swiss NTN Innovative Surfaces. He completed his studies in Materials Sciences (2000) as well as his PhD in Polymer Technology (2004) at ETH Zürich. In 2004, he joined Ciba Specialty Chemicals working first on supramolecular additives for breathable films, and electret filters and later focusing on stabilizers, functional additives and nanoparticles.

Since 2009, he is Professor in Polymer Nanotechnology at FHNW. His research focuses on the functionalization of polymers by micro/nanostructuring, surface grafting and bulk modification for life science and optics applications. Per Magnus Kristiansen is author/co-author of 17 papers and 5 patent applications.

linked-in 

Medical Advisors.

Prof. Daniel Lew, MD

Prof. Daniel Lew, MD

Prof. Daniel Lew, MD, is clinical infectious diseases physician and President of the Clinical Ethics Committee of the Geneva University Hospitals as well as Honorary Professor of Medicine at the University of Geneva Medical School. He is President of the Swiss Academic Foundation for Education in Infectious Diseases and member of the Swiss Academy of Medical Sciences. He obtained his MD degree from Geneva University in 1976 and specialized in infectious diseases both in Geneva and then subsequently at Harvard Medical School and Massachusetts General Hospital in Boston, USA. In the past he served as Chief of the Service of Infectious Diseases, and Chief of the Academic Department of Internal Medicine at the Geneva University Hospital.

He is a recipient of numerous scientific awards and grants for his research work. Professor Lew lectures widely, acts both as reviewer and editor for several major scientific journals, and is author of many publications on neutrophil function, bacterial pathogenesis and drug resistance. Prof. Daniel Lew is past President of the International Society for Infectious Diseases (ISID).

linked-in

 Dr. Vladimir Velebit, MD

Dr. Vladimir Velebit, MD

Vladimir Velebit, MD, is a Swiss board specialist in General Surgery and Swiss board specialist in Cardiac and Thoracic Vascular surgery. He has a cardiac and vascular surgery practice at the Hôpital de la Tour, Meyrin-Geneva, Switzerland. Vladimir has been the vice-president (2009) and president (2010) of the Medical Society of Geneva. He is the president of the Foundation Surgical Overseas Services, Geneva. He is a member of the board of the Frederic and Jean Maurice Foundation, Geneva.

He has been involved in cardiac surgery in former Yugoslavia since 1998 as the Head of Clinical Services Open Heart Clinic, Tbilisi, Georgia and the Primarius Department of Cardio-vascular Surgery, University Hospital, Sarajevo, Bosnia and Herzegovina.

linked-in

 Dr. Benjamin Crocker, MD

Dr. Benjamin Crocker, MD

Benjamin Crocker, MD, is a general internist and serves as Medical Director of the Ambulatory Practice of the Future (APF) at the Massachusetts General Hospital. Since the opening of APF, Ben has been intimately involved in the hiring and development of the APF team, building and implementing the practice’s strategic plan of operations, developing practice guidelines and policies, expanding urgent care services, and designing team building activities and team development processes.

He received two additional Winickoff fellowship awards to examine point-of-care testing in primary care, and the use of practice-based health coaching in exercise wellness. Ben is a co-developer of the Innovation Learning Program and has collaborated on APF practice evaluation projects with graduate students from both Harvard Business School and MIT Sloan School of Management.

linked-in

 Dr. Kent Lewandrowski, MD

Dr. Kent Lewandrowski, MD

Kent Lewandrowski, MD, is an Associate Chief for Laboratory and Molecular Medicine at the Massachusetts General Hospital. He is a Professor of Pathology at Harvard Medical School with research interests in pancreatic pathology and the evaluation of point-of-care technologies.

Dr. Lewandrowski was trained in anatomic and clinical pathology at the Massachusetts General Hospital and has been on the staff of the department of Pathology since 1991. He is also editor in chief of the medical journal “Point of Care: The Journal of Near Patient Testing Technology”.

linked-in

Pin It on Pinterest